Improvement in Stress, General Self-Efficacy, and Health Related Quality of Life following Patient Education for Patients with Neuroendocrine Tumors: A Pilot Study

Table 4

Adjusted mixed-effect models for longitudinal mean changes in stress, general self-efficacy, and mental and physical component scores (𝑛=37).

Variables	Step 2 explanatory model: stress; estimate (SE)	Step 2 explanatory model: general self-efficacy; estimate (SE)	Step 2 explanatory model: mental component scores; estimate (SE)	Step 2 explanatory model: physical component scores; estimate (SE)
Intercept (baseline)	22.9 (9.1)	33.78 (2.56)	43.08 (1.50)	55.08 (5.33)
Change over time	−2.10 (0.78)^b	0.71 (0.33)^a	0.36 (0.96)	3.09 (0.91)^b
Gender (women)	−2.73 (3.96)	−1.17 (1.03)		1.65 (2.87)
Time * gender				−2.77 (1.29)^a
Age	−0.02 (0.01)	−0.03 (0.64)		− 0.13 (0.08)
Comorbidity (Yes)	1.85 (4.34)	1.06 (1.22)		−8.47 (2.45)^b
Symptoms (≥1)	7.96 (2.3)^b	−0.31 (0.64)		−4.86 (1.58)^b

Age is based on the mean of the sample.
Significance level: ^a: 𝑃 < 0.05; ^b: 𝑃 < 0.01.
Abbreviations: SE: standard error of the mean.